Miscellaneous Cardiovascular Medications

Question 1

Metoprolol brand name

Answer 1

Lopressor
Toprol XL

Question 2

Clonidine brand name

Answer 2

Catapres
Kapvay

Question 3

Hyrdalazine brand name

Answer 3

Apresoline

Question 4

Nitroglycerin brand names

Answer 4

Minitran
Nitrostat
Nitro-dur

Question 5

Ranolazine brand

Answer 5

Ranexa

Question 6

Sacubitril/Valsartan

Answer 6

Entresto

Question 7

Digoxin brand

Answer 7

Digitek
Lanoxin

Question 8

Amiodarone brand

Answer 8

Codarone
Pacerone

Question 9

Anorexia and diarrhea are common ADRs associated with this cardiac drug
a.Codarone
b.Digoxin
c.Entresto
d.Ranexa

Answer 9

Digoxin

Question 10

This drug is a beta-adrenergic blocker
a. clonidine
b. hydralizine
c. nitroglycerin
d. metoprolol

Answer 10

Metoprolol

Question 11

Pregnancy and the use of an ACEI within 36 hours are majorly contraindicated in patients on this medication
a.digoxin
b.entresto
c. pacerone
d.ranolazine

Answer 11

Entresto

Question 12

CNS effects like dizziness, drowsiness, fatigue and dry mouth are in association with this drug
a.clonidine
b. metoprolol
c.digoxin
d.amiodarone

Answer 12

clonidine

Question 13

Abrupt withdrawal in patients with coronary artery disease is a BBW for this medication
a.entresto
b.apresoline
c.metoprolol
d.nitrostat

Answer 13

metoprolol

Question 14

Syncope is a serious ADR associated with this these drugs. Select all that applies
a.Nitroglycerin
b.Digoxin
c.Hydralizine
d.Clonidine
e.Ranolazine

Answer 14

Nitroglycerin and Clonidine

Question 15

Hepatic cirrhosis, concurrent use of strong CYP3A inhibitors and inducers should be avoided in patients on this mediation
a.Ranolazine
b. Sacubitril/Valsartan
c.Digoxin
d.Amiodarone

Answer 15

Ranolazine

Question 16

The MOA of this drug involves inhibition of adrenergic stimulation, affects sodium, potassium and calcium channels as well as prolongs action potential and refractory period in myocardial tissue; decreases AV conduction and sinus node function
a.Lanoxin
b.Amiodarone
c.Entresto
d.Metoprolol

Answer 16

Amiodarone

Question 17

Drug induced lupus erythematosus(DILE) at high doses is a serious ADR in patients on this medication
a. Clonidine
b. Hydralazine
c. Digoxin
d. Nitroglycerin

Answer 17

Hydralazine

Question 18

Use of this drug with phosphodiesterase 5 inhibitors such as sildenafil and tadalafil are contraindicated
a.Ranexa
b.Entresto
c.Digitek
d.Minitran

Answer 18

Minitran

Question 19

Stimulation of alpha-2-adrenoreceptors in the brain stem activating of an inhibitory neuron, resulting in reduced sympathetic outflow from the CNS is a MOA of this drug
a.Metoprolol
b.Ranexa
c.Kapvay
d.Apresoline

Answer 19

Kapvay

Question 20

This drug is indicated for chest pain, hypertension and heart failure with reduced ejection fraction
a.Nitroglycerin
b.Lopressor
c.Toprol XL
d.Ranolazine

Answer 20

Nitroglycerin

Question 21

Constipation and QT Prolongation are common and serious ADR for this drug
a.Entresto
b.Ranolzaine
c.Hydralazine
d.Digoxin

Answer 21

Ranolazine

Question 22

Pregnancy is a black box warning for this drug
a.Digoxin
b.Entresto
c.Amiodarone
d.Clonidine

Answer 22

Entresto

Question 23

This drug forms free radical nitric oxide in blood vessel walls which creates a vasodilator effect on the peripheral veins and arteries with more effect on the veins
a.Toprol Xl
b.Digoxin
c.Nitroglycerin
d.Amiodarone

Answer 23

Nitroglycerin

Question 24

This drug is indicated for hypertension, heart failure with reduced ejection fraction
a. Lopressor
b.Nitrostat
c.Kapvay
d.Apresoline

Answer 24

Apresoline

Question 25

This drug is a combination of ARB/Neprilysin inhibitor. Its MOA includes decreasing the breakdown of natriuretic peptides; inducing vasodilation and natriuresis a. Metoprolol b. Hydralazine c. Ranolazine d. Entresto

Answer 25

Entresto

Question 26

Direct suppression of the AV node conduction to increase effective refractory period and decrease conduction velocity. Inhibition of the sodium/potassium ATPase pump in myocardial cells results in a transient increase of intracellular sodium, increasing contractility is a MOA of a. Nitrostat b. Digoxin c. Amiodarone d. Entresto

Answer 26

Digoxin

Question 27

Arrhythmias, hepatoxicity, proarrhythmic effects and pulmonary toxicity are black box warnings for this drug a.Entresto b.Lanoxin c.Codarone d.Ranexa

Answer 27

Codarone

Question 28

Key Counselling: This medication is for your heart failure. May cause dizziness(worsens when dehydrated).It should be avoided in pregnancy. Use potassium supplements/salt substitutes only under medical supervision.

Answer 28

Sacubitril/Valsartan(Entresto)

Question 29

When on this drug it may require you to have your blood drawn confirm you are receiving a safe and effective dose. a.Nitrostat b.Digoxin c.Amiodarone d.Entresto

Answer 29

Digoxin

Question 30

This drug is contraindicated in persons with Coronary artery disease a.troprol xl b.minitran c.hydralazine d.digioxin

Answer 30

Hydralazine